SIM
OKUR

Sonora Investment Management’s OnKure Therapeutics OKUR Stock Holding History

Sonora Investment Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Hold
8
– – ﹤0.01% 1063
2021
Q2 		$1K Buy
+8
New +$892 ﹤0.01% 971

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sonora Investment Management's OKUR Position: Q3 2021 in Review

Sonora Investment Management held its OnKure Therapeutics (OKUR) position steady in Q3 2021 at 8 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1063.

Sonora Investment Management first reported a position in OKUR in Q2 2021 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold OKUR as of Q3 2021.

  • Sonora Investment Management held 8 shares of OnKure Therapeutics worth $1K as of Q3 2021.
  • Sonora Investment Management left its OnKure Therapeutics share count unchanged in Q3 2021.
  • OnKure Therapeutics made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #1063 holding.
  • Sonora Investment Management first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.